This is a Validated Antibody Database (VAD) review about rat Csnk2b, based on 5 published articles (read how Labome selects the articles), using Csnk2b antibody in all methods. It is aimed to help Labome visitors find the most suited Csnk2b antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Csnk2b synonym: Ck2; casein kinase II subunit beta; CK II beta; Csnk2b splicing isoform 280; Csnk2b splicing isoform 662; Csnk2b-Ly6g5b; casein kinase 2, beta polypeptide; casein kinase 2, beta subunit; casein kinase II beta subunit; chimera Csnk2b-Ly6g5b splicing isoform 2050; chimera Csnk2b-Ly6g5b splicing isoform 2275; chimera Csnk2b-Ly6g5b splicing isoform 2531; chimera Csnk2b-Ly6g5b splicing isoform 901; phosvitin

Santa Cruz Biotechnology
mouse monoclonal (6D5)
  • western blot; human; 1:100; loading ...; fig 2d
  • immunocytochemistry; mouse; 1:50; loading ...; fig 3a
  • western blot; mouse; 1:100; loading ...; fig 2d
Santa Cruz Biotechnology Csnk2b antibody (SantaCruz, sc-12739) was used in western blot on human samples at 1:100 (fig 2d), in immunocytochemistry on mouse samples at 1:50 (fig 3a) and in western blot on mouse samples at 1:100 (fig 2d). Nat Commun (2017) ncbi
mouse monoclonal (E-9)
  • immunocytochemistry; rat; 1:25; loading ...; fig 1
Santa Cruz Biotechnology Csnk2b antibody (Santa Cruz, sc-46666) was used in immunocytochemistry on rat samples at 1:25 (fig 1). Cell Signal (2016) ncbi
mouse monoclonal (E-9)
  • western blot; human
Santa Cruz Biotechnology Csnk2b antibody (Santa Cruz, sc-46666) was used in western blot on human samples . Mol Cell Pharmacol (2014) ncbi
mouse monoclonal (6D5)
  • western blot; human; fig 1
Santa Cruz Biotechnology Csnk2b antibody (Santa Cruz Biotechnology, sc-12739) was used in western blot on human samples (fig 1). Breast Cancer Res (2015) ncbi
mouse monoclonal (E-9)
  • western blot; human; fig 1
Santa Cruz Biotechnology Csnk2b antibody (Santa Cruz Biotechnology, sc-46666) was used in western blot on human samples (fig 1). Breast Cancer Res (2015) ncbi
Sigma-Aldrich
mouse monoclonal (6D5)
  • western blot; rat; 1:1500; fig 4
Sigma-Aldrich Csnk2b antibody (Sigma, C3617) was used in western blot on rat samples at 1:1500 (fig 4). Eur J Neurosci (2014) ncbi
Articles Reviewed
  1. Kang Y, Balter B, Csizmadia E, Haas B, Sharma H, Bronson R, et al. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival. Nat Commun. 2017;8:14013 pubmed publisher
  2. Spohrer S, Dimova E, Kietzmann T, Montenarh M, Götz C. The nuclear fraction of protein kinase CK2 binds to the upstream stimulatory factors (USFs) in the absence of DNA. Cell Signal. 2016;28:23-31 pubmed publisher
  3. Trembley J, Unger G, Gomez O, Abedin J, Korman V, Vogel R, et al. Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation. Mol Cell Pharmacol. 2014;6:15-25 pubmed
  4. Kren B, Unger G, Abedin M, Vogel R, Henzler C, Ahmed K, et al. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Breast Cancer Res. 2015;17:19 pubmed publisher
  5. Lussier M, Gu X, Lu W, Roche K. Casein kinase 2 phosphorylates GluA1 and regulates its surface expression. Eur J Neurosci. 2014;39:1148-58 pubmed publisher